FTC Targets Supplement Firm In Administrative Proceeding After Contempt Complaint Fails

Federal Judge Says Settlement Stipulation Against ‘Treats Disease’ Claims Is Ambiguous

A ruling in Maine federal court questions whether FTC could show firms made claims a product labeled as a supplement “cures, mitigates, or treats any disease." But agency's administrative complaint includes the same phrase as a stipulation among the penalties it would order.

The Federal Trade Commission pivots to an administrative proceeding in its litigation against a dietary supplement firm after a court ruled that terms US regulators commonly use to define noncompliant claims are vague and unenforceable as a stipulation in a settlement the FTC allowed the firm to enter.

After the FTC allowed Maine businesses Health Research Laboratories LLC and Whole Body Supplements LLC and their owner, Kramer Duhon,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation